TFCP2L1 and urinary bladder cancer: Moreover, high co‐expression of TFCP2L1 and CDK1 in tumor tissues of bladder cancer patients was associated with unfavorable clinical features, including high tumor grade, lymphovascular and muscularis propria invasion, and distant metastasis, and was an independent prognostic factor for cancer‐specific survival.